SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rajiv G. Tawar, Che C. Colpitts, Jörg Timm, Tanja Fehm, Michael Roggendorf, Helga Meisel, Nicolas Meyer, François Habersetzer, François-Loïc Cosset, Thomas Berg, Mirjam B. Zeisel, Thomas F. Baumert, Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties, Hepatology, 2015, 62, 2
  2. 2
    Shuang Sun, Guojiang Jin, Hui Kang, CD81 and CLDN1 polymorphisms and hepatitis C virus infection susceptibility: A case–control study, Gene, 2015, 567, 1, 87

    CrossRef

  3. 3
    Laurent Mailly, Fei Xiao, Joachim Lupberger, Garrick K Wilson, Philippe Aubert, François H T Duong, Diego Calabrese, Céline Leboeuf, Isabel Fofana, Christine Thumann, Simonetta Bandiera, Marc Lütgehetmann, Tassilo Volz, Christopher Davis, Helen J Harris, Christopher J Mee, Erika Girardi, Béatrice Chane-Woon-Ming, Maria Ericsson, Nicola Fletcher, Ralf Bartenschlager, Patrick Pessaux, Koen Vercauteren, Philip Meuleman, Pascal Villa, Lars Kaderali, Sébastien Pfeffer, Markus H Heim, Michel Neunlist, Mirjam B Zeisel, Maura Dandri, Jane A McKeating, Eric Robinet, Thomas F Baumert, Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody, Nature Biotechnology, 2015, 33, 5, 549

    CrossRef

  4. 4
    Muriel Lavie, François Penin, Jean Dubuisson, HCV envelope glycoproteins in evirion assembly and entry, Future Virology, 2015, 10, 3, 297

    CrossRef

  5. 5
    P Padmanabhan, NM Dixit, Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other Classes, CPT: Pharmacometrics & Systems Pharmacology, 2015, 4, 7
  6. 6
    F. Xiao, I. Fofana, C. Thumann, L. Mailly, R. Alles, E. Robinet, N. Meyer, M. Schaeffer, F. Habersetzer, M. Doffoel, P. Leyssen, J. Neyts, M. B. Zeisel, T. F. Baumert, Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C, Gut, 2015, 64, 3, 483

    CrossRef

  7. 7
    Florian Douam, Viet Loan Dao Thi, Guillemette Maurin, Judith Fresquet, Dimitri Mompelat, Mirjam B. Zeisel, Thomas F. Baumert, François-Loïc Cosset, Dimitri Lavillette, Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry, Hepatology, 2014, 59, 3
  8. 8
    Nicholas S Eyre, Karla J Helbig, Michael R Beard, Current and future targets of antiviral therapy in the hepatitis C virus life cycle, Future Virology, 2014, 9, 11, 947

    CrossRef

  9. 9
    Isabel Fofana, Nikolaus Jilg, Raymond T. Chung, Thomas F. Baumert, Entry inhibitors and future treatment of hepatitis C, Antiviral Research, 2014, 104, 136

    CrossRef

  10. 10
    Andrea Magri, Simone Bocchetta, Michela Emma Burlone, Rosalba Minisini, Mario Pirisi, Recent advances in HCV entry, Future Virology, 2014, 9, 2, 189

    CrossRef

  11. 11
    Jean Dubuisson, François-Loïc Cosset, Virology and cell biology of the hepatitis C virus life cycle – An update, Journal of Hepatology, 2014, 61, 1, S3

    CrossRef

  12. 12
    Daniel Felmlee, Mohamed Hafirassou, Mathieu Lefevre, Thomas Baumert, Catherine Schuster, Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease, Viruses, 2013, 5, 5, 1292

    CrossRef

  13. 13
    Jason M. Meyer, Gregory A. Graf, Deneys R. van der Westhuyzen, New developments in selective cholesteryl ester uptake, Current Opinion in Lipidology, 2013, 1

    CrossRef

  14. 14
    François Habersetzer, Céline Leboeuf, Michel Doffoël, Mirjam B Zeisel, Thomas F Baumert, Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2013, 22, 7, 853

    CrossRef

  15. 15
    Brett D. Lindenbach, Charles M. Rice, The ins and outs of hepatitis C virus entry and assembly, Nature Reviews Microbiology, 2013, 11, 10, 688

    CrossRef

  16. 16
    Guillaume Desoubeaux, Arnaud Daguet, Hervé Watier, Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012, mAbs, 2013, 5, 5, 626

    CrossRef

  17. 17
    Guillaume Desoubeaux, In vitro Studies and Clinical Trials about Monoclonal Antibodies Used in Infectiology,